The Journal of Neuropsychiatry and Clinical Neurosciences
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by Bowers, M. B.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Bowers, M. B., Jr

J Neuropsychiatry Clin Neurosci 1996; 8:450-452
Copyright © 1996 by American Neuropsychiatric Association

REGULAR ARTICLES

Plasma HVA and MHPG in psychiatric patients with renal failure and levodopa-treated Parkinson's disease

MB Bowers Jr
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, USA.

Plasma homovanillic acid (HVA), but not plasma 3-methoxy-4- hydroxyphenylglycol (MHPG), was substantially increased in 4 patients undergoing hemodialysis, 3 patients with chronic renal failure, and 3 patients receiving carbidopa/levodopa for Parkinson's disease. These conditions should be considered in psychiatric research involving plasma HVA.




Get information about faster international access.

Privacy Policy

Copyright © 1996 American Neuropsychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Neuropsychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org